Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Quell Therapeutics Appoints Dominik Hartl, M.D., as Chief Medical Officer
Quell Therapeutics Ltd (“Quell”), the world leader in developing engineered T-regulatory (Treg) cell therapies for […]
Elevar Therapeutics Announces CEO Transition and New Board Appointment
Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating […]
Pfizer Announces New Investor Relations Leader
Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior […]
Calyxt Appoints Michael A. Carr as Chief Executive Officer
Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A. Carr as President […]
Ada Expands its Global Leadership Team to Help Drive Company’s Rapid Growth
Ada, the global health company, today announces the appointment of digital transformation veterans Gülsah Wilke, […]
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Transine Therapeutics, a biotechnology company developing a novel class of therapeutic RNAs based on its […]
Presidio Medical Announces Appointment of New Chief Executive Officer
Presidio Medical, Inc., a clinical-stage medical device company developing a transformational neuromodulation platform, today announced […]
Amphista Therapeutics Expands Research Team by Appointing Martin O'Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry
Amphista Therapeutics, a Targeted Protein Degradation (TPD) biopharmaceutical company creating first-in-class cancer therapeutics that harness […]
Rt Hon Sajid Javid MP Appointed Secretary of State for Health and Social Care
The Queen has been pleased to approve the appointment of the Rt Hon Sajid Javid […]
Caresyntax Adds Industry Leaders to Advisory Board
Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more